Best Practices

Managing High-Risk Patients With Acute Coronary Syndrome


 

A supplement to Cardiology News. This supplement was sponsored by Merck.
Written by Paul Cerrato, Medical Writer


Topics

• Acute coronary syndrome
• Acute myocardial infarction
• GP IIb/IIIa inhibitors
• Eptifibatide
• Cardiology
• percutaneous coronary intervention

Faculty/Faculty Disclosures

Marc Cohen, MD, FACC
Director
Division of Cardiology
Newark Beth Israel
Medical Center
Newark, New Jersey
Professor of Medicine
Mount Sinai School
of Medicine
New York, New York

Dr Cohen has disclosed that he has served as an advisor or consultant for Bristol-Myers Squibb, Datascope, and sanofi-aventis; has received grant/research support from Bristol-Myers Squibb, Cordis, and Datascope; and has served as a speaker or a member of a speakers bureau for Bristol-Myers Squibb, Merck, and sanofi-aventis.

To view the supplement, click the image above.

Next Article: